Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Prostaglandins Other Lipid Mediat ; 169: 106764, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37459907

RESUMO

Caloric restriction (CR) is a dietetic intervention based on the reduction of daily calorie intake by 10-30 %. When subjected to CR, the organism adjusts its metabolism to the changing availability of key nutrients. However, fatty acids' content in organisms subjected to long-term CR has not been evaluated. The aim of the research was to analyze the influence of long-term CR on the contents of medium- and long-chain fatty acids, as well as on the contents of fatty acid derivatives in liver. The study was performed on C57BL female (n = 12) and male (n = 12) mice subjected to lifelong 30 % calorie restriction. Fatty acids were analyzed using gas chromatography, while fatty acid derivatives were analyzed with liquid chromatography. The dynamics of change of the lipid profile of the labeled fatty acids observed in the liver tissue confirms that lipolysis actively takes place in this organ when hungry. Moreover, it is highly possible that de novo synthesis of acids takes place, with the aim to ensure energy substrates to the body. Moreover, an increase of concentration was observed for fatty acid derivatives, those with anti-inflammatory properties (resolvin, LTX A4). However, there was no increase in the concentration of pro-inflammatory eicosanoids. The results suggest that it is important to take into consideration the introduction of appropriate supplements when using CR.


Assuntos
Restrição Calórica , Ácidos Graxos , Masculino , Feminino , Camundongos , Animais , Ácidos Graxos/metabolismo , Camundongos Endogâmicos C57BL , Fígado/metabolismo
2.
Eur Rev Med Pharmacol Sci ; 24(18): 9684-9694, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-33015813

RESUMO

OBJECTIVE: Several human trials have confirmed that Lactobacillus plantarum 299v (Lp299v) relief the gastrointestinal symptoms observed in patients with irritable bowel syndrome, such as nausea, vomiting, and diarrhea. These symptoms are similar to those associated with home enteral nutrition and they affect nutritional status as well as patients' quality of life. The aims of this study were to determine the effect of Lp299v on nutritional status, enteral formula tolerance, and quality of life in cancer patients. PATIENTS AND METHODS: The current double-blind, randomized, and placebo-controlled study included 35 cancer patients receiving home enteral nutrition. There were 2 groups of participants consuming either 2 x 10^10 CFU of Lp299v (n=21) or placebo (n=14) for 4 weeks. RESULTS: An increase in the serum albumin concentration was significantly higher in the Lp299v group than in the placebo group at the endpoint (p=0.032). Moreover, the changes in the frequency of vomiting and flatulence were significantly reduced at week 4 compared to baseline in the Lp299v group (p=0.0117). The improvement of quality of life was observed in both groups; however, with no statistically significant differences between the analyzed groups (p>0.05). CONCLUSIONS: We have demonstrated that administration of Lp299v in cancer patients receiving home enteral nutrition may improve laboratory parameters, predominantly the concentration of albumin, however, overall it does not have an impact on nutritional status. Lp299v may reduce the gastrointestinal symptoms related to enteral nutrition; notwithstanding, the improvement of quality of life may be the result of enteral nutrition rather than the effect of administration of Lp299v.


Assuntos
Suplementos Nutricionais/microbiologia , Nutrição Enteral , Serviços de Assistência Domiciliar , Lactobacillus plantarum/isolamento & purificação , Neoplasias/dietoterapia , Probióticos/uso terapêutico , Albuminas/análise , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estado Nutricional , Probióticos/administração & dosagem , Qualidade de Vida , Resultado do Tratamento
3.
Eur Rev Med Pharmacol Sci ; 23(21): 9667-9680, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31773718

RESUMO

OBJECTIVE: Gut microbiota provide a diverse "organ" or biocenosis responsible for protection against pathogens and the development of both intestinal and immune systems. Microbiota are also responsible for the synthesis of vitamins and short-chain fatty acids, which in turn affect the host's metabolism. It was hypothesized that gut microbiota are influenced by fetal life followed by intensive development throughout the first years of life. MATERIALS AND METHODS: We analyzed the available literature (PubMed, Embase, Google Scholar) on prenatal and early childhood development of gut microbiota. RESULTS: A body of evidence suggests in utero colonization. The main factors determining gut microbiota include the type of delivery and post-natal feeding method. The composition of the intestinal flora is also influenced by fetal age at birth, antibiotic therapy, pre- and probiotic supplementation, and other environmental factors. The multifaceted nature of this process guarantees the uniqueness of its composition for each human being. CONCLUSIONS: Although the composition of intestinal microbiota is subject to continuous and dynamic changes, it seems that the perinatal period is critical for the emergence of its proper pattern, which may guarantee health or otherwise illness in adult life.


Assuntos
Antibacterianos/farmacologia , Desenvolvimento Infantil/efeitos dos fármacos , Microbioma Gastrointestinal/efeitos dos fármacos , Feminino , Humanos , Recém-Nascido , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA